zhang lingyun

Prof. zhang lingyun

Assistant experimenter
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2022 in Cells
Verified
Journal Article
Open access
PDF file
JZJiantao Zhao
Jiantao Zhao
XWXuemei Wang
Xuemei Wang
姿霍姿君 霍
姿君 霍
YCYanchun Chun
Yanchun Chun
JLJinmeng Liu
Jinmeng Liu
Shuanhu ZhouShuanhu Zhou
Shuanhu Zhou
Amyotrophic lateral sclerosis (ALS) is a rapidly progressive and highly fatal neurodegenerative disease. Although the pathogenesis of ALS remains unclear, increasing evidence suggests that a key contributing factor is mitochondrial dysfunction. Mitochondria are organelles in eukaryotic cells responsible for bioenergy production, cellular metabolism, signal transduction, calcium homeostasis, and immune responses and the stability of their function plays a crucial role in neurons. A single disorder or defect in mitochondrial function can lead to pathological changes in cells, such as an impaired calcium buffer period, excessive generation of free radicals, increased mitochondrial membrane permeability, and oxidative stress (OS). Recent research has also shown that these mitochondrial dysfunctions are also associated with pathological changes in ALS and are believed to be commonly involved in the pathogenesis of the disease. This article reviews the latest research on mitochondrial dysfunction and its impact on the progression of ALS, with specific attention to the potential of novel therapeutic strategies targeting mitochondrial dysfunction.

7 February 2022 in Cells
Verified
Journal Article
Open access
PDF file
JLJinmeng Liu
Jinmeng Liu
FZfenghua zhou
fenghua zhou
YGYinjun Guan
Yinjun Guan
FMFandi Meng
Fandi Meng
ZZZhenhan Zhao
Zhenhan Zhao
XWXin Wang
Xin Wang
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects upper and lower motor neurons. As there is no effective treatment for ALS, it is particularly important to screen key gene therapy targets. The identifications of microRNAs (miRNAs) have completely changed the traditional view of gene regulation. miRNAs are small noncoding single-stranded RNA molecules involved in the regulation of post-transcriptional gene expression. Recent advances also indicate that miRNAs are biomarkers in many diseases, including neurodegenerative diseases. In this review, we summarize recent advances regarding the mechanisms underlying the role of miRNAs in ALS pathogenesis and its application to gene therapy for ALS. The potential of miRNAs to target diverse pathways opens a new avenue for ALS therapy.

22 March 2023 in Cells
Verified
Journal Article
Open access
PDF file
HDHongmei Du
Hongmei Du
姿霍姿君 霍
姿君 霍
YCYanchun Chun
Yanchun Chun
ZZZhenhan Zhao
Zhenhan Zhao
FMFandi Meng
Fandi Meng
XWXin Wang
Xin Wang
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that results in the loss of motor function in the central nervous system (CNS) and ultimately death. The mechanisms underlying ALS pathogenesis have not yet been fully elucidated, and ALS cannot be treated effectively. Most studies have applied animal or single-gene intervention cell lines as ALS disease models, but they cannot accurately reflect the pathological characteristics of ALS. Induced pluripotent stem cells (iPSCs) can be reprogrammed from somatic cells, possessing the ability to self-renew and differentiate into a variety of cells. iPSCs can be obtained from ALS patients with different genotypes and phenotypes, and the genetic background of the donor cells remains unchanged during reprogramming. iPSCs can differentiate into neurons and glial cells related to ALS. Therefore, iPSCs provide an excellent method to evaluate the impact of diseases on ALS patients. Moreover, patient-derived iPSCs are obtained from their own somatic cells, avoiding ethical concerns and posing only a low risk of immune rejection. The iPSC technology creates new hope for ALS treatment. Here, we review recent studies on iPSCs and their applications in disease modeling, drug screening and cell therapy in ALS, with a particular focus on the potential for ALS treatment.

26 November 2024 in PeerJ
Verified
Journal Article
Open access
PDF file
ZWZihao Wang
Zihao Wang
QYQiupeng Yan
Qiupeng Yan
ZWZhen Wang
Zhen Wang
ZHZunguo Hu
Zunguo Hu
CWChenchen Wang
Chenchen Wang
YCYanchun Chen
Yanchun Chen
Ferroptosis, a recently recognized form of regulated cell death (RCD) characterized by iron-dependent lipid peroxide accumulation, has emerged as a noteworthy regulator in various bone-related diseases, including osteoporosis (OP), osteoarthritis (OA), and osteosarcoma (OS). OS primarily afflicts the elderly, rendering them susceptible to fractures due to increased bone fragility. OA represents the most prevalent arthritis in the world, often observed in the aging population. OS predominantly manifests during adolescence, exhibiting an aggressive nature and bearing a significantly unfavorable prognosis. In this review article, we present an overview of the characteristics and mechanism of ferroptosis and its involvement in bone-related diseases, with a particular focus on OP, OA, and OS. Furthermore, we summarize chemical compounds or biological factors that impact bone-related diseases by regulating ferroptosis. Through an in-depth exploration of ferroptosis based on current research findings, this review provides promising insights for potential therapeutic approaches to effectively manage and mitigate the impact of these bone-related pathological conditions.

1 December 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
YLYingxue Li
Yingxue Li
YCYaoyao Chang
Yaoyao Chang
JFJianfang Fu
Jianfang Fu
RDRongcai Ding
Rongcai Ding
ZLzhang lingyun
zhang lingyun
JHJinxing Hu
Jinxing Hu